Services on Demand
Journal
Article
Indicators
- Cited by SciELO
- Access statistics
Related links
- Similars in SciELO
Share
Archivos de cardiología de México
On-line version ISSN 1665-1731Print version ISSN 1405-9940
Abstract
BARRANCO-GARDUNO, Lina et al. Clinical evidence of the antiarrhythmic effect of a magistral suspension of propafenone: A case report. Arch. Cardiol. Méx. [online]. 2009, vol.79, n.2, pp.132-134. ISSN 1665-1731.
Propafenone is an antiarrhythmic that has been used for the treatment of tachiarrytmias in both adults and children. The aim of this study was to analyze the pharmacologic effect of a magistral suspension of propafenone, due to lack of an adequate commercial formulation for use in children. In this study we present, a case of a 2-year-old boy that was diagnosed with Wolff-Parkinson White syndrome and treated with a magistral suspension of propafenone. He has now been one year with no symptoms, no tachycardia and no cyanosis. The clinical status of the patient under treatment with propafenone was improved through constant medical care in the Cardiological Health Care Unit. The use of a magistral formulation of propafenone developed in our laboratory offers a temporal solution due to lack of medicines for children.
Keywords : Antiarrhythmic agent; Children; Pharmacology; Propafenone; Supra ventricular tachycardia; Mexico.